CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Assembly Bio Announces Promotions to Leadership Team

Life Sciences Review Life Sciences Review | Tuesday, August 17, 2021
Tweet

Okazaki joined Assembly Bio as chief legal and business officer in 2020, where he was in charge of leading and executing strategic collaborations and transactions. Samar has headed Assembly Bio’s financial and business operations since joining the company in 2017, most recently as senior vice president of finance and business operations.


FREMONT, CA: Assembly Biosciences, a clinical-stage biotechnology company developing advanced therapeutics targeting Hepatitis B Virus (HBV), recently announced the promotions of Jason Okazaki to chief operating officer and Michael Samar to chief financial officer. Okazaki joined Assembly Bio as chief legal and business officer in 2020, where he was in charge of leading and executing strategic collaborations and transactions. Samar has headed Assembly Bio’s financial and business operations since joining the company in 2017, most recently as senior vice president of finance and business operations.


“Jason and Michael are highly skilled in their respective professions and as business leaders; together, they have brought to bear their years of industry experience to positively impact Assembly Bios business, finance and operations and ensure we are well-positioned to meet our long-term objectives,” said John McHutchison, AO, MD, chief executive officer and president of Assembly Bio. “Their expert counsel and strategic guidance have been invaluable and they have made important contributions to our growth. Im thrilled to recognize their leadership with these promotions and look forward to our continued work together as we pursue finite and curative therapies for HBV.”


Okazaki comes to Assembly Bio with 20 years of business and legal experience, including 14 years as senior vice president, legal, and assistant secretary at Gilead Sciences. 


He oversaw a global legal team that supported businesses in the United States, Asia, and Latin America and provided corporate governance and SEC reporting advice.


Okazaki was also in charge of all acquisitions, strategic collaborations, licensing agreements, and structuring and legal implementation. He formerly worked as an associate in the mergers and acquisitions and corporate finance divisions at Skadden, Arps, Slate, Meagher &Flom LLP. Okazaki earned a bachelor’s degree from Stanford University and a Juris Doctor (JD) degree from UC Hastings College of the Law. He is a member of the California and New York State Bars.


Samar has over 20 years of experience overseeing finance and business operations for firms in the life sciences industry and assisting transactions such as IPOs, financings, and M&A. He formerly worked at Acorda Therapeutics as vice president of finance (formerly Biotie Therapies).


Samar previously worked at Onyx Pharmaceuticals as the director of financial planning and analysis; Agennix (formerly GPC Biotech) as the senior finance director of global planning and analysis; and Johnson & Johnson Pharmaceutical Research & Development as the director of financial planning and analysis. He has a master’s degree in business administration from Villanova University and a bachelor’s degree in finance from Bryant University.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/assembly-bio-announces-promotions-to-leadership-team-nwid-504.html